IKBKB and adenoma: In a colitis-associated colon cancer model, we previously found that deletion of Ikkβ in myeloid cells reduces the incidence as well as the size of adenomas due to decreased expression of pro-inflammatory cytokines which promote tumor cell proliferation [11].